Board meeting on 29 October 2026 to consider unaudited results for September quarter
Lincoln Pharmaceuticals has scheduled a Board meeting for Thursday, 29th October, 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Thursday, 29th October, 2026
- Results Period
- quarter and half year ended September 30, 2026
- Trading Window Closure
- closed from October 01, 2026; reopens 48 hours after results become generally available
Board meeting set for 29th October, 2026
The company has told the National Stock Exchange of India Limited and BSE Limited that its Board of Directors will meet on Thursday, 29th October, 2026.
- The board will consider and approve the un-audited financial results, both standalone and consolidated, for the quarter and half year ended September 30, 2026.
- Any other business may be taken up with the permission of the Chairman.
The intimation is signed by Trusha Shah, Company Secretary and Compliance Officer.
Standalone and consolidated, in plain words
- Standalone results show the company's own operations.
- Consolidated results club in the company along with its subsidiaries and other group entities.
- Reading both together shows how the core business did and how the whole group did.
Trading window is shut
The company has also said that, under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window has been closed for trading in the company's securities from October 01, 2026.
- It will reopen after the expiry of 48 hours from the time the results become generally available.
- This means people classified as insiders are not free to buy or sell the company's shares until that window reopens.
What this announcement is, and is not
This is a notice of a board meeting date. The actual numbers, and whatever the board decides on them, come when the results are considered and approved at that meeting.
What to watch for
- The un-audited standalone and consolidated results for the quarter and half year ended September 30, 2026, once the board considers and approves them.
- The date the results become generally available, since the trading window reopens 48 hours after that.
Also from Lincoln Pharmaceuticals
Senior General Manager - Quality Assurance resigns with effect from October 17, 2026
17 Oct 2026
Senior General Manager - Quality Assurance appointed as Senior Management Personnel
24 Sep 2026
Head of Quality Assurance resigns with effect from September 24, 2026
24 Sep 2026
More numbers
- Trading window reopens after expiry of48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.